BBNX (Beta Bionics) Interest Coverage: N/A (As of Mar. 2026)


BBNX Beta Bionics Inc BBNX
10 GF Score
Price $17.00
! 3 Warning Signs
View Full Analysis

What is Beta Bionics Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Beta Bionics's Operating Income for the three months ended in Mar. 2026 was $-24.3 Mil. Beta Bionics's Interest Expense for the three months ended in Mar. 2026 was $0.0 Mil. GuruFocus does not calculate 's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Beta Bionics Inc has enough cash to cover all of its debt. Its financial situation is stable.

The historical rank and industry rank for Beta Bionics's Interest Coverage or its related term are showing as below:


BBNX's Interest Coverage is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 15.875
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Beta Bionics  (NAS:BBNX) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Beta Bionics Interest Coverage Related Terms


Beta Bionics Interest Coverage Historical Data

* Premium members only.

The historical data trend for Beta Bionics's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Beta Bionics Interest Coverage Chart

Beta Bionics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Interest Coverage
0.00 0.00 N/A N/A

Beta Bionics Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

BBNX vs CBLL, SIBN, TCMD: Interest Coverage Comparison

For the Medical Devices subindustry, Beta Bionics's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beta Bionics Interest Coverage vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beta Bionics's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Beta Bionics's Interest Coverage falls into.


BBNX
10GF Score
Beta Bionics Inc BBNX
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beta Bionics Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Beta Bionics's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, Beta Bionics's Interest Expense was $0.0 Mil. Its Operating Income was $-71.7 Mil. And its Long-Term Debt & Capital Lease Obligation was $5.4 Mil.

GuruFocus does not calculate Beta Bionics's interest coverage with the available data.

Beta Bionics's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Here, for the three months ended in Mar. 2026, Beta Bionics's Interest Expense was $0.0 Mil. Its Operating Income was $-24.3 Mil. And its Long-Term Debt & Capital Lease Obligation was $5.1 Mil.

GuruFocus does not calculate Beta Bionics's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Beta Bionics Business Description

Address 11 Hughes, Irvine, CA, USA, 92618
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
10GF Score

Get the complete analysis for BBNX

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.00
Price